Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments
- PMID: 40252164
- PMCID: PMC12085338
- DOI: 10.1007/s12325-025-03185-9
Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments
Abstract
Diabetes mellitus is a metabolic disorder, characterized by elevated blood sugar levels (hyperglycemia) and insulin dysregulation. This disease is associated with morbidity and mortality, including significant potential vascular complications. High levels of hyperglycemia lead to not only elevated levels of reactive oxygen species but also advanced glycation end products, which are detrimental to the vascular endothelium and reduce protective compounds such as nitric oxide and prostacyclin. This damage contributes to the development of both macrovascular and microvascular complications. The present investigation explores the pathophysiological mechanisms of diabetic vascular complications and evaluates current management strategies, including lifestyle modifications, pharmacological treatments, and emerging therapies. The review underscores the importance of ongoing progress in diabetes management and patient education to lead to optimal patient-health outcomes and quality of life for individuals with diabetes mellitus.
Keywords: Diabetes mellitus; Endothelial dysfunction; Hyperglycemia; Pharmacological treatments; Vascular complications.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of Interest: Alan D Kaye is an Editorial Board member of Advances in Therapy. Alan Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. All other authors (Kazi Islam, Rahib Islam, Ivan Nguyen, Hassan Malik, Humza Pirzadah, Barsha Shrestha, Isabella B. Lentz and Sahar Shekoohi) declare no conflict of interest. Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Similar articles
-
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.Diabetes Metab. 2001 Sep;27(4 Pt 1):436-47. Diabetes Metab. 2001. PMID: 11547217 Review.
-
Postprandial hyperglycemia as an etiological factor in vascular failure.Cardiovasc Diabetol. 2009 Apr 29;8:23. doi: 10.1186/1475-2840-8-23. Cardiovasc Diabetol. 2009. PMID: 19402896 Free PMC article. Review.
-
[Endothelial dysfunction in type 1 diabetes].Arq Bras Endocrinol Metabol. 2008 Mar;52(2):416-26. doi: 10.1590/s0004-27302008000200030. Arq Bras Endocrinol Metabol. 2008. PMID: 18438553 Review. Portuguese.
-
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.Acta Pharmacol Sin. 2019 Jan;40(1):1-8. doi: 10.1038/s41401-018-0042-6. Epub 2018 Jun 4. Acta Pharmacol Sin. 2019. PMID: 29867137 Free PMC article. Review.
-
[Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress].Wien Med Wochenschr. 2011 Jun;161(11-12):305-14. doi: 10.1007/s10354-011-0868-8. Epub 2011 Mar 7. Wien Med Wochenschr. 2011. PMID: 21360292 German.
Cited by
-
The crucial role of potassium ion channels in diabetes mellitus and its complications: A review.Channels (Austin). 2025 Dec;19(1):2531949. doi: 10.1080/19336950.2025.2531949. Epub 2025 Jul 12. Channels (Austin). 2025. PMID: 40650956 Free PMC article. Review.
References
-
- Sapra A, Bhandari P. Diabetes. In: StatPearls. Treasure Island: StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK560927/.
-
- Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, de Clerck E, Polivka J, Potuznik P, Polivka J, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation. EPMA J. 2023;14:21–42. 10.1007/s13167-023-00314-8. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical